Captopril: Difference between revisions

Revision as of 14:10, 28 March 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amr Marawan, M.D. [2], Ahmed Zaghw, M.D. [3]

Captopril tablet is an angiontensin converting enzyme inhibitor drug that is FDA approved for the treatment of hypertension, heart failure, left ventricular dysfunction after myocardial infarction, diabetic nephropathy. Adverse reactions include hypotension, rash, hyperkalemia, disorder of taste, cough. hypotension, rash, hyperkalemia, disorder of taste, cough.

@@ Line 2: / Line 2: @@
 {{CMG}}; {{AE}} {{AM}}, {{AZ}}
-'''''For patient information about Captopril, click [[Captopril (patient information)|here]].'''''
+===''[[Captopril tablet|Captopril]]''===
+* [[Captopril tablet]]
+===''[[Captopril and Hydrochlorothiazide]]''===
-{{SB}} Capoten
+* [[Captopril and Hydrochlorothiazide tablet]]
 ==Overview==
@@ Line 13: / Line 17: @@
 Antihypertensive Agents, Angiotensin Converting Enzyme Inhibitors.
-==Prescribing Information==
-===''[[Captopril tablet|Captopril]]''===
-* [[Captopril tablet]]
-===''[[Captopril and Hydrochlorothiazide]]''===
-* [[Captopril and Hydrochlorothiazide tablet]]